Imperial Innovations builds and invests in technology and healthcare businesses based on or associated with leading scientific research from the UK’s four leading universities: Imperial College London, Cambridge, Oxford and University College London.

Since admission to AIM in 2006, we have raised over £200 million to invest in and grow technology and healthcare businesses based on pioneering research undertaken at the four universities we focus on. We have invested £121 million in this time, and our portfolio of companies has raised £408 million.